Summary
Keio University and Waseda University have worked together on artificial O2 carrier research for 20 years in close cooperation. Two candidate materials have been selected from the viewpoints of safety, efficacy, and cost performance. One is Hemoglobin-vesicles (HbV) and the other is albumin-heme (rHSA-heme). This chapter summarizes our video presentation that introduced the recent results of our research into HbV and rHSA-heme.
Chapter PDF
Similar content being viewed by others
References
Tsuchida E (ed) (1991) Macromolecular complexes, dynamic interactions and electronic processes. VCH New York
Ciardelli F, Tsuchida E, Wöhrle D (eds) (1996) Macromolecule-metal complexes. VCH New York
Matsushita Y, Hasegawa E, Eshima K, et al (1983) Synthesis of amphiphilic porphinatoiron complexes having phosphocholine groups. Chem Lett 1983:1387–1389
Tsuchida E (1985) Liposome-embedded iron-porphyrins as an artificial oxygen carrier. Ann New York Acad Sci 446:429–442
Tsuchida E, Nishide H (1986) Hemoglobin model—artificial oxygen carrier composed of porphinatoiron complexes. Top Curr Chem 132:63–99
Tsuchida E, Nishide H (1988) Liposome/heme as a totally synthetic oxygen transporter. In: Greoriadis G (ed) Liposomes as drug carriers, Wiley, Chichester, pp 569–582
Chang TMS (1997) Blood substitutes: principles, methods, products, and clinical trials. Karger, Basel
Riess JG (2001) Oxygen carriers (Blood Substitutes)-raison d’etre, chemistry, and some physiology. Chem Rev 101:2797–2919
Sloan EP, Koenigsberg M, Gens D, et al (1999) Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock. JAMA 282:1857–1864
Tsuchida E (1998) Blood substitutes: present and future perscpectives. Elsevier, Amsterdam
Djordjevich L, Mayoral J, Miller IF, et al (1987) Cardiorespiratory effects of exchange transfusions with synthetic erythrocytes in rats. Crit Care Med 15:318–323
Takeoka S, Ohgushi T, Sakai H, et al (1993) Preparation conditions of human hemoglobin vesicles covered with lipid membrane. Artif Organs Today 3:129–136
Sakai H, Takeoka S, Yokohama H, et al (1993) Purufication of concentrated Hb using organic solvent and heat treatment. Protein Expression Purif 4:563–569
Takeoka S, Ohgushi T, Terase K, et al (1996) Layer-controlled hemoglobin vesicles by interaction of hemoglobin with a phospholipid assembly. Langmuir 12:1755–1759
Naito Y, Fukutomi I, Masada Y, et al (2002) Virus removal from hemoglobin solution using Planova membrane. J Artif Organs 5:141–145
Fukutomi I, Sakai H, Takeoka S, et al (2002) Carbonylation of oxyhemoglobin solution using a membrane oxygenator. J Artif Organs 5:102–107
Sou K, Endo T, Takeoka S, et al (2000) Poly(ethylene glycol)-modification of the phospholipids vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles. Bioconjugate Chem 11:372–379
Sakai H, Tomiyama K, Sou K, et al (2000) Poly(ethyleneglycol)-conjugation and deoxygenation enable long term preservation of hemoglobin vesicles as oxygen carriers. Bioconjugate Chem 11:425–432
Sou K, Naito Y, Endo T, et al (2003) Effective encapsulation of proteins into size-controlled phospholipid vesicles using the freeze-thawing and extrusion. Biotechnol Prog 19
Izumi Y, Sakai H, Hamada K, et al (1996) Pysiologic responses to exchange transfusion with hemoglobin vesicels as an artificial oxygen carrier in anesthetized rats: changes in mean arterial pressure and renal cortical tissue oxygen tension. Crit Care Med 24:1869–1873
Izumi Y, Sakai H, Takeoka S, et al (1997) Evaluation of the capabilities of a hemoglobin vesicle as an artificial oxygen carrier in a rat exchange transfusion model ASAIO J. 43:289–297
Kobayashi K, Izumi Y, Yoshizu A, et al (1997) The oxygen carrying capability of hemoglobin vesicles evaluated in rat exchange transfusion models. Artif Cells Blood Substitues Immobilization Biotechnol 25:357–366
Sakai H, Park SI, Kose T, et al (1997) Surface modification of hemoglobin vesicles with poly(ethyleneglycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjugate Chem 8:23–30
Sakai H, Tsai AG, Kerger H, et al (1998) Subcutaneous microvascular responses to hemodilution with a red cell substitute consisting of polyethyleneglycol-modified vesicles encapsulating hemoglobin. J Biomed Materials Res 40:66–78
Sakai H, Tsai AG, Rohlfs RJ, et al (1999) Microvascular responses to hemodilution with Hb-vesicles as red cell substitutes: Influences of O2 affinity. Am J Physiol 276 (Heart Circ Physiol 45):H553–H562
Sakai H, Takeoka S, Wettstein R, et al (2002) Systemic and Microvascular responses to the hemorrhagic shock and resuscitation with Hb-vesicles. Am J Physiol Heart Circ Physiol 283:H1191–H1199
Erni D, Wettstein R, Schramm S, et al (2003) Normovolemic hemodilution with hemoglobin-vesicle solution attenuates hypoxia in ischemic hamster flap tissue. Am J Physiol Heart Circ Physiol 284:H1702–H1709
Contaldo C, Schramm S, Wettstein R, et al (2003) Improved oxygenation in ischemic hamster flap tissue is correlated with increasing hemodilution with Hb vesicles and their O2 affinity. Am J Physiol Heart Circ Physiol 284
Goda N, Suzuki K, Naito S, et al (1998) Distribution of heme oxygenase isoform in rat liver: topographic basis for carbon monoxide-mediated micorvascular relaxation. J Clin Invest 101:604–612
Sakai H, Hara H, Yuasa M, et al (2000) Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension in conscious hamster model. Am J Physiol Heart Circ Physiol 279:H908–H915
Wakamoto S, Fujiwara M, Abe H, et al (2001) Effects of PEG-modified hemoglobin vesicles on agonist induced platelet aggregation and RANTES release in vitro. Artif Cells Blood Substitues Immobilization Biotechnol 29:191–201
Kyokane T, Norimizu S, Taniai H, et al (2001) Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology 120:1227–1240
Ito T, Fujihara M, Abe H, et al (2001) Effects of poly (ethyleneglycol)-modified hemoglobin vesicles on N-formyl-methionyl-leucyl-phenylalanine induced respoonses of polymorphonuclear neutrophils in vitro. Artif Cells Blood Substitues Immobilization Biotechnol 29:427–438
Sakai H, Horinouchi H, Tomiyama K, et al (2001) Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial systems. Am J Pathol 159:1079–1088
Sakai H, Tomiyama K, Masada Y, et al (2003) Pretreatment of serum containing Hb-vesicels (oxygen carriers) to avoid their interference in laboratory tests. Clin Chem Lab Med 41:222–231
Curry S, Mandelkow H, Brick P, et al (1998) Crystal structure of human serum albumin complexes with fatty acid reveals an asymmetric distribution of binding sites. Nature Struct Biol 5:827–835
Sumi A, Ohtani W, Kobayashi K, et al (1993) Purification and Physicochemical Properties of Recombinant Human Serum Albumin. In: Rivat C, Stoltz J-F (eds) Biotechnology of Blood Proteins Vol. 227, John Libbey Eurotext Montrouge, pp 293–298
Komatsu T, Ando K, Kawai N, et al (1995) O2-Transport Albumin: A New Hybrid-haemoprotein Incorporating Tetraphenylporphinatoiron(II) Derivative. Chem Lett 1995:813–814
Tsuchida E, Ando K, Maejima H, et al (1997) Properties of oxygen binding by albumin-tetraphenylporphyrynatoiron(II) derivative complexes. Bioconjugate Chem 8:534–538
Wu J, Komatsu T, Tsuchida E (1998) Resonance raman studies of O2-binding to ortho-substituted tetraphenyl-and tetranaphthyl-porphinatoiron(II) derivatives with a covalently linked axial imidazole. J Chem Soc Dalton Trans 1998:2503–2506
Komatsu T, Hamamatsu K, Wu J, et al (1999) Physicochemical properties and O2-coordination structure of human serum albumin incorporating tetrakis(o-pivalamido) phenylporphinatoiron(II) serivatives. Bioconjugate Chem 10:82–86
Tsuchida E, Komatsu T, Mastukawa Y, et al (1999) Human serum albumin incorporating tetrakis(o-pivalamido)phenylporphinatoiron(II) derivative as a totally synthetic O2-carrying hemoprotein. Bioconjugate Chem 10:797–802
Komatsu T, Matsukawa Y, Tsuchida E (2000) Kinetics of CO and O2 Binding to Human Serum Albumin-heme Hybrid. Bioconjugate Chem 11:772–776
Komatsu T, Matsukawa Y, Tsuchida E (2001) Reaction of Nitric Oxide with Synthetic Hemoprotein, Human Serum Albumin Incorporating Tetraphenylporphinatoiron(II) Derivatives. Bioconjugate Chem 12:71–75
Nakagawa A, Komatsu T, Tsuchida E (2001) Photoreduction of autooxidized albumin-heme hybrid in saline solution: revival of its O2-binding ability. Bioconjugate Chem 12:648–652
Komatsu T, Okada T, Moritake M, et al (2001) O2-Binding properties of double-sided porphyrinatoiron(II)s with polar substituents and their human serum albumin hybrids. Bull Chem Soc Jpn 74:1695–1702
Wu Y, Komatsu T, Tsuchida E (2001) Electrochemical studies of albumin-heme hybrid in aqueous media by modified electrode. Inorg Chim Acta 322:120–124
Komatsu T, Matsukawa Y, Tsuchida E (2002) Effect of heme structure on O2-binding properties of human serum albumin-heme hybrids: intramolecular histidine coordination provides a stable O2-adduct complex. Bioconjugate Chem 13:397–402
Tsuchida E, Komatsu T, Yanagimoto T, et al (2002) Preservation stability and in vivo administration of albumin-heme hybrid solution as an entirely synthetic O2-carrier. Polym Adv Technol 13:845–850
Nakagawa A, Komatsu T, Ohmichi N, et al (2003) Synthetic dioxygen-carrying hemoprotein: human serum albumin including iron(II) complex of protoporphyrin IX with an axially coordinated histidylglycyl-propionate. Chem Lett 32:504–505
Tsuchida E, Komatsu T, Matsukawa Y, et al (2003) Human serum albumin incorporating synthetic heme: red blood cell substitute without hypertension by nitric oxide scavenging. J Biomed Mater Res 64A:257–261
Tsuchida E, Komatsu T, Hamamatsu K, et al (2000) Exchange transfusion of albumin-heme as an artificial O2-infusion into anesthetized rats: physiological responses, O2-delivery and reduction of the oxidized hemin sites by red blood cells. Bioconjugate Chem 11:46–50
Komatsu T, Hamamatsu K, Tsuchida E (1999) Cross-linked human serum albumin dimers incorporating sixteen (tetraphenylporphinato)iron(II) derivatives: synthesis, characterization, and O2-binding property. Macromolecules 32:8388–8391
Kobayashi K, Komatsu T, Iwamaru A, et al (2003) Oxygenation of hypoxic region in solid tumor by administration of human serum albumin incorporating synthetic hemes. J Biomed Mater Res 64A:48–51
Kobayashi K, Izumi Y, Yamahata T, et al (1996) Efficacy of synthetic oxygen-carrying substances. In: Proceedings of Int. Congr. Ser. 1995. Elsevier, pp 305–310
Horinouchi H, Tajima A, Kobayashi K (2001) Liquid ventilation using artificial oxygen carrier. Artif Blood 9:2–5 (in Japanese)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this paper
Cite this paper
Kobayashi, K. et al. (2005). Safety and Efficacy of Hemoglobin-Vesicles and Albumin-Hemes. In: Kobayashi, K., Tsuchida, E., Horinouchi, H. (eds) Artificial Oxygen Carrier. Keio University International Symposia for Life Sciences and Medicine, vol 12. Springer, Tokyo. https://doi.org/10.1007/4-431-26651-8_1
Download citation
DOI: https://doi.org/10.1007/4-431-26651-8_1
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-22074-9
Online ISBN: 978-4-431-26651-8
eBook Packages: MedicineMedicine (R0)